TSS
ENVB icon

Two Sigma Securities’s Enveric Biosciences ENVB Stock Holding History

Two Sigma Securities’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-177
Closed -$11.4K – 1650
2024
Q4 		$11.4K Buy
177
+7
+4% +$508 ﹤0.01% 1420
2024
Q3 		$14.5K Buy
170
+85
+100% +$7.82K ﹤0.01% 2543
2024
Q2 		$9.54K Buy
+85
New +$12.8K ﹤0.01% 2808
2019
Q3 		– Hold
0
– -$7K – 2140
2019
Q2 		– Hold
0
– – – 2011
2019
Q1 		– Hold
0
– – – 1694
2018
Q4 		– Hold
0
– -$16K – 2320
2018
Q3 		– Hold
0
– – – 2466

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Securities's ENVB Position: Q1 2025 in Review

Two Sigma Securities sold out of Enveric Biosciences (ENVB) in Q1 2025, closing a stake of 177 shares — an estimated $11.4K sold.

Two Sigma Securities first reported a position in ENVB in Q2 2024 and held it in 3 quarters. The position peaked at $14.5K in Q3 2024. 13 funds tracked by Wall St. Rank hold ENVB as of Q1 2025.

  • Two Sigma Securities reported no remaining Enveric Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 177 Enveric Biosciences shares in Q1 2025, an estimated $11.4K.
  • Two Sigma Securities first reported a position in Enveric Biosciences in Q2 2024 and held it in 3 quarters.
  • Two Sigma Securities's Enveric Biosciences position peaked at $14.5K in Q3 2024.
  • 13 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.